Roadmap to a Cure

Objective: A cure to end Alzheimer's for those afflicted and prevent it for those at risk

Our Roadmap to a Cure by 2020

Cure Alzheimer’s Fund is the only research organization with a real plan to end Alzheimer’s disease. Our unique funding strategy is 100% focused on finding a cure and supports the scientists doing the most innovative work to move knowledge of Alzheimer’s pathology most expeditiously to prevention and cure. Our ultimate objective is to stop the disease before it even starts.

By addressing the problem at the root and finding the major causes of the disease, we are already accelerating developments of effective therapies. The projects we fund are based on our roadmap, which we believe is the quickest way to a cure.

In the drug development phase, we will find therapies that can most safely and effectively disrupt the genetic links that cause Alzheimer’s disease through:

  • Preclinical testing
  • Human clinical trials in partnership with drug companies
  • Working with drug companies to make new therapies available to patients

The new drugs that our researchers develop will be used not only to treat Alzheimer’s but to prevent it in those with greatest genetic risk. By predicting risk early, we can prevent the disease before it begins its destructive course.